Mar 24, 2003
HEMISPHERX BIOPHARMA APPOINTS DR. JAMES KNILL VICE PRESIDENT OF CLINICAL DEVELOPMENT OF THE HIV/AIDS DIVISION

Mar 20, 2003
HEMISPHERX BIOPHARMA TO PRESENT AT THE STRATEGIC RESEARHC INTSTITUTES FIRST 'siRNA' CONFERENCE

Mar 18, 2003
REBROADCAST OF HEMISPHERX'S MARCH 18, 2003 CONFERENCE CALL AVAILABLE ON COMPANY'S WEBSITE OR VIA TELEPHONE REPLAY

Mar 13, 2003
HEMISPHERX TO HOST CONFERENCE CALL ON TUESDAY, MARCH 18, 2003 AT 11:00AM EST

Mar 12, 2003
HEMISPHERX ACQUIRES RIGHTS FOR THE ONLY FDA APPROVED NATURAL ALPHA INTERFERON DRUG Company Completes a $5,500,000 Private Placement Conference Call to be Held On Tuesday, March 18, 2003 at 11:00am EST

Mar 06, 2003
Hemispherx Biopharma to Present New Interim Clinical Data Regarding Phase IIB Study in HIV/AIDS at the 16th International Conference on Antiviral Research

Feb 12, 2003
Expanded Clinical Data on AmpligenÒ in HIV Disease to be presented at the 16th International Conference on Antiviral Research

Jan 31, 2003
Hemispherx Presents New Data on Long-term, Post-trial Effects of RNA-based Ampligen(R) for Treatment for Chronic Fatigue Syndrome

Jan 24, 2003
HEMISPHERX ANNOUNCES TAGLICH BROTHERS RELEASE OF UPDATED RESEARCH REPORT

Jan 22, 2003
REBROADCAST OF HEMISPHERX'S JANUARY 21, 2003 CONFERENCE CALL AVAILABLE ON COMPANY'S WEBSITE OR VIA TELEPHONE REPLAY

 65   66   67   68   69     70    71   72   73   74   75